R. Ikeuchi

Utilization rate and long‐term persistence of combination pharmacotherapy with β3‐agonists and antimuscarinics for overactive bladder refractory to monotherapy in a real‐world setting

T. Soda, T. Okada, S. Koike, 2022, Neurourology and urodynamics.

Overactive bladder medication: Persistence, drug switching, and reinitiation

T. Soda, Yumiko Tashiro, Shuhei Koike, 2020, Neurourology and urodynamics.